Log in to save to my catalogue

Impaired nicotinamide adenine dinucleotide (NAD+) metabolism in diabetes and diabetic tissues: Impli...

Impaired nicotinamide adenine dinucleotide (NAD+) metabolism in diabetes and diabetic tissues: Impli...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_3188bef211c64148b0d36d6522a5c541

Impaired nicotinamide adenine dinucleotide (NAD+) metabolism in diabetes and diabetic tissues: Implications for nicotinamide‐related compound treatment

About this item

Full title

Impaired nicotinamide adenine dinucleotide (NAD+) metabolism in diabetes and diabetic tissues: Implications for nicotinamide‐related compound treatment

Publisher

Japan: John Wiley & Sons, Inc

Journal title

Journal of diabetes investigation, 2020-11, Vol.11 (6), p.1403-1419

Language

English

Formats

Publication information

Publisher

Japan: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

One of the biochemical abnormalities found in diabetic tissues is a decrease in the cytosolic oxidized to reduced forms of the nicotinamide adenine dinucleotide ratio (NAD+/NADH also known as pseudohypoxia) caused by oxidation of excessive substrates (glucose through the polyol pathway, free fatty acids and lactate). Subsequently, a decline in NAD+...

Alternative Titles

Full title

Impaired nicotinamide adenine dinucleotide (NAD+) metabolism in diabetes and diabetic tissues: Implications for nicotinamide‐related compound treatment

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_3188bef211c64148b0d36d6522a5c541

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_3188bef211c64148b0d36d6522a5c541

Other Identifiers

ISSN

2040-1116

E-ISSN

2040-1124

DOI

10.1111/jdi.13303

How to access this item